Skip to content

Vamandhauti procedure and Shivapalapindi Choorna administration in Gastric disease

To Evaluate the efficacy of Vamana dhauti with and without Shivapalapindi in Amlapitta

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031950
Enrollment
60
Registered
2021-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: 1- Vaman dhauti 2- Shivapalapindi: 1- giving lukewarm saline water and making the patient vomit. Dose - Duration - Route of Administration - 2-Shivapalapindi contains dravyas like P

Sponsors

Dr Chaudhari Krishnakumari B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Subjects between the age group of 18 to 40 yrs, irrespective of gender, religion, occupation & socio - economic status. - Subjects having the Classical symptoms of amlapitta as described in Ayurvedic literature will be included.

Exclusion criteria

Exclusion criteria: - Subjects with any other systemic illness like Hypertension, Diabetes mellitus. - Previously diagnosed cases of ulceration of stomach, esophagus, and duodenum, CA of G.I tract and crohnâ??s disease. - Subjects who are not fit for Vaman dhauti will be excluded. - Pregnant lady & lactating women will be excluded.

Design outcomes

Primary

MeasureTime frame
Reduce in the sign and symptoms of AmlapittaTimepoint: 30 days

Secondary

MeasureTime frame
other associated symptoms of amlapitta will reduce.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr CHAUDHARI KRISHNAKUMARI B

Government Ayurveda Medical College Mysuru

nisargarekha@gmail.com8073046886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026